BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12468520)

  • 1. The inhibitory effect of (111)In-DTPA(0)-octreotide on intrahepatic tumor growth after partial hepatectomy.
    Slooter GD; Aalbers AG; Breeman WA; Hiemstra CA; Marquet RL; Krenning EP; van Eijck CH
    J Nucl Med; 2002 Dec; 43(12):1681-7. PubMed ID: 12468520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
    Hofland LJ; Lamberts SW; van Hagen PM; Reubi JC; Schaeffer J; Waaijers M; van Koetsveld PM; Srinivasan A; Krenning EP; Breeman WA
    J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide receptor radionuclide therapy in vitro using [111In-DTPA0]octreotide.
    Capello A; Krenning EP; Breeman WA; Bernard BF; de Jong M
    J Nucl Med; 2003 Jan; 44(1):98-104. PubMed ID: 12515882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
    De Jong M; Breeman WA; Bernard HF; Kooij PP; Slooter GD; Van Eijck CH; Kwekkeboom DJ; Valkema R; Mäcke HR; Krenning EP
    Q J Nucl Med; 1999 Dec; 43(4):356-66. PubMed ID: 10731786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
    Forssell-Aronsson EB; Nilsson O; Bejegård SA; Kölby L; Bernhardt P; Mölne J; Hashemi SH; Wängberg B; Tisell LE; Ahlman H
    J Nucl Med; 2000 Apr; 41(4):636-42. PubMed ID: 10768564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver.
    Slooter GD; Breeman WA; Marquet RL; Krenning EP; van Eijck CH
    Int J Cancer; 1999 May; 81(5):767-71. PubMed ID: 10328231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size.
    de Jong M; Breeman WA; Bernard BF; Bakker WH; Visser TJ; Kooij PP; van Gameren A; Krenning EP
    J Nucl Med; 2001 Dec; 42(12):1841-6. PubMed ID: 11752083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
    De Jong M; Valkema R; Jamar F; Kvols LK; Kwekkeboom DJ; Breeman WA; Bakker WH; Smith C; Pauwels S; Krenning EP
    Semin Nucl Med; 2002 Apr; 32(2):133-40. PubMed ID: 11965608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.
    Barone R; Walrand S; Konijnenberg M; Valkema R; Kvols LK; Krenning EP; Pauwels S; Jamar F
    Nucl Med Commun; 2008 Mar; 29(3):283-90. PubMed ID: 18349800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(111)In-DTPA]octreotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapy.
    Pool SE; Kam BL; Koning GA; Konijnenberg M; Ten Hagen TL; Breeman WA; Krenning EP; de Jong M; van Eijck CH
    Cancer Biother Radiopharm; 2014 May; 29(4):179-87. PubMed ID: 24820805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat.
    Stolz DB; Mars WM; Petersen BE; Kim TH; Michalopoulos GK
    Cancer Res; 1999 Aug; 59(16):3954-60. PubMed ID: 10463591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood transfusion causes deterioration in liver regeneration after partial hepatectomy in rats.
    Okano T; Ohwada S; Nakasone Y; Sato Y; Ogawa T; Tago K; Morishita Y
    J Surg Res; 2001 Dec; 101(2):157-65. PubMed ID: 11735271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
    Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
    Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small mammal model of tumour implantation, dissemination and growth factor expression after partial hepatectomy.
    Aalbers AG; ten Kate M; van Grevenstein WM; Hofland LJ; Wiemer EA; Jeekel J; van Eijck CH
    Eur J Surg Oncol; 2008 Apr; 34(4):469-75. PubMed ID: 17442529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there any effect of renal failure on the hepatic regeneration capacity following partial hepatectomy in rats?
    Kawai T; Yokoyama Y; Nagino M; Kitagawa T; Nimura Y
    Biochem Biophys Res Commun; 2007 Jan; 352(2):311-6. PubMed ID: 17126297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkaline phosphatase reduces hepatic and pulmonary injury in liver ischaemia -- reperfusion combined with partial resection.
    van Veen SQ; Dinant S; van Vliet AK; van Gulik TM
    Br J Surg; 2006 Apr; 93(4):448-56. PubMed ID: 16491472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regenerative activity and liver function following partial hepatectomy in the rat using (31)P-MR spectroscopy.
    Corbin IR; Buist R; Volotovskyy V; Peeling J; Zhang M; Minuk GY
    Hepatology; 2002 Aug; 36(2):345-53. PubMed ID: 12143042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ischemic preconditioning on regenerative capacity of hepatocyte in the ischemically damaged rat livers.
    Bedirli A; Kerem M; Pasaoglu H; Erdem O; Ofluoglu E; Sakrak O
    J Surg Res; 2005 May; 125(1):42-8. PubMed ID: 15836849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.